Amgen Inc Net Income per Employee (AMGN), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Amgen Inc   (NASDAQ: AMGN)
 

Amgen Inc Net Income per Employee

AMGN's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 20.15% in the third quarter 2026, year on year to cumulative value of $9,391 million, and with 13,000 employees, Amgen Inc 's income per employee grew on trailing twelve month basis to $ 722,385. The income per employee at Amgen Inc ' was above the company average.
The Healthcare sector has seen employees of 9 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 287, from total ranking in previous quarter at 373.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AMGN Net Income per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Net Income Change 20.15 % 65.85 % 5.14 % 112.6 % 13.64 %
Net Income per Employee (TTM) $ 722,385 672,538 600,000 593,154 538,846
AMGN's Total Ranking # 287 # 373 # 306 # 287 # 305
Seq. Net Income Change 62.69 % 30.57 % 36.46 % -58.55 % 124.58 %

AMGN Company Profile >> Back to AMGN Efficiency Comparisons >> Compare AMGN Net Income per Employee to its Competitors

AMGN Net Income per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 10
Healthcare Sector # 39
Overall Market # 287

Net Income per Employee Statistics
High Average Low
$ 672,538 $ 414,821 $ 152,231
(Jun 30 2026)   (Dec 31 2017)







Companies with similar Income per Employee for 12 month ending Sep 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2026Number of Employees Sep 30 2026
Halozyme Therapeutics Inc   1,147,565.01 $ 485.420  Million 423 
Ligand Pharmaceuticals Incorporated  1,094,936.17 $ 51.462  Million 47 
Alnylam Pharmaceuticals Inc   1,089,695.60 $ 2,724.239  Million 2,500 
Nurix Therapeutics Inc   930,211.36 $ 294.877  Million 317 
Krystal Biotech Inc   763,281.36 $ 225.168  Million 295 
Illumina Inc   699,218.75 $ 895.000  Million 1,280 
Black Hawk Acquisition Corporation  649,852.50 $ 1.300  Million 2 
Eli Lilly And Company  551,594.00 $ 27,579.700  Million 50,000 
Acadia Pharmaceuticals Inc   453,921.05 $ 362.229  Million 798 
Indivior Pharmaceuticals Inc   451,000.00 $ 451.000  Million 1,000 
Alector Inc   402,067.96 $ 41.413  Million 103 
Denali Therapeutics Inc   393,667.99 $ 198.015  Million 503 


Date modified: 2026-11-06T12:53:18+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.